Asian investor commits $15M to launch new protein degradation biotech startup Cullgen out of UNC
A Japan-based investor with close ties to Chinese research circles is backing a new biotech upstart in the US with its own take on the hot field of protein degradation.
Tokyo-based GNI Group is providing up to $15 million to seed the work at a newco called Cullgen, the brainchild of UNC investigator Yue Xiong. While still very much a fledgling, the company’s launch plans call for research to be undertaken in the US, Japan as well as China.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
